Medical Care Technologies Inc (MDCE)
OTHER OTC:MDCE
Want to see MDCE full AI Analyst Report?
Top Page
Medical Care Technologies
(OTC:MDCE)
Select Model
Select Model
Rating:56Neutral
Price Target:―
Action:Reiterated
Date:05/19/26
The score is primarily driven by financial performance: a conservatively levered balance sheet and improved profitability support the rating, but uneven revenue/margins and inconsistent cash generation materially increase risk. Limited technical data and a negative P/E (with no dividend yield provided) further constrain the score.
Positive Factors
Low leverage / balance sheet strength
Very low debt and higher equity/assets vs. 2023 give the company durable financial flexibility. This conservatism reduces refinancing and solvency risk, enabling the firm to fund operations, opportunistic acquisitions, or restructuring without immediate reliance on volatile external markets.
Negative Factors
Volatile revenues and margins
Historical swings in revenue and margins undermine predictability of future earnings and planning. Volatility constrains management's ability to commit to sustained investments, complicates forecasting, and increases the chance that recent margin improvements may reverse under stress or uneven demand.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / balance sheet strength
Very low debt and higher equity/assets vs. 2023 give the company durable financial flexibility. This conservatism reduces refinancing and solvency risk, enabling the firm to fund operations, opportunistic acquisitions, or restructuring without immediate reliance on volatile external markets.
Read all positive factors
Medical Care Technologies (MDCE) vs. SPDR S&P 500 ETF (SPY)
Market Cap
N/A
Dividend YieldN/A
Average Volume (3M)N/A
Price to Earnings (P/E)―
Beta (1Y)-0.41
Revenue Growth44.64%
EPS GrowthN/A
CountryUS
Employees1
SectorConsumer Cyclical
Sector Strength84
IndustryShell Companies
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.70
Price to Sales (P/S)1.21
P/FCF Ratio8.36
Enterprise Value/Market Cap10.00T>
Enterprise Value/Revenue0.44
Enterprise Value/Gross Profit0.86
Enterprise Value/Ebitda2.24
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Medical Care Technologies Business Overview & Revenue Model
Company Description
Medical Care Technologies Inc., a development stage company, engages in opening and operating children's integrated health and wellness centers in China. The company sells and distributes pharmaceutical and nutraceutical products, and other mercha...
How the Company Makes Money
null...
Medical Care Technologies Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
78
Positive
Cash Flow
48
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.05M | 1.07M | 656.40K | 731.97K | 3.47M |
| Gross Profit | 532.24K | 576.12K | 321.85K | -57.24K | 1.33M |
| EBITDA | 204.76K | 238.06K | 152.99K | 0.00 | 1.33M |
| Net Income | 198.16K | 230.77K | 150.38K | -387.51K | 1.10M |
Balance Sheet | |||||
| Total Assets | 1.87M | 1.89M | 1.47M | 603.46K | 1.05M |
| Cash, Cash Equivalents and Short-Term Investments | 476.45K | 490.55K | 52.34K | 35.39K | 11.80K |
| Total Debt | 43.05K | 10.00K | 67.67K | 39.14K | 27.94K |
| Total Liabilities | 61.90K | 26.68K | 82.03K | 69.48K | 124.01K |
| Stockholders Equity | 1.81M | 1.86M | 1.38M | 533.98K | 921.49K |
Cash Flow | |||||
| Free Cash Flow | 68.88K | 155.47K | -616.08K | 29.91K | 139.55K |
| Operating Cash Flow | 68.88K | 155.47K | -616.08K | 29.91K | 139.55K |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 92.04K | 70.13K | 633.03K | -6.32K | -127.75K |
Medical Care Technologies Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | $7.70M | 9.48 | 48.22% | ― | 13.70% | ― | |
56 Neutral | ― | -5.88 | 15.97% | ― | 44.64% | ― | |
48 Neutral | $32.51M | ― | ― | ― | ― | ― | |
43 Neutral | $1.89M | -0.10 | -3734.39% | ― | -8.90% | 80.07% | |
39 Underperform | $1.50M | -0.27 | ― | ― | -66.15% | 85.60% |
* Consumer Cyclical Sector Average
MDCE
Medical Care Technologies
―
―
―
NAAS
NaaS Technology
3.13
-1.67
-34.90%
NVVE
Nuvve Holding
0.38
-36.34
-98.96%
VMAR
Vision Marine Technologies
0.66
-255.34
-99.74%
MRM
MEDIROM Healthcare Technologies
1.27
-0.23
-15.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.